Skip to main content
. Author manuscript; available in PMC: 2022 May 26.
Published in final edited form as: Mol Cancer Res. 2021 Jan 29;19(5):913–920. doi: 10.1158/1541-7786.MCR-20-0738

Figure 5: Gilteritinib induces G0/G1 cell cycle arrest in ALCL cells:

Figure 5:

DEL and SU-DHL-1 cells were treated with the indicated concentration of gilteritinib for 24 hours. Cells were fixed and stained with propidium iodide, and cell cycle status was determined by flow cytometry. Values represent the mean of three independent experiments. Bars represent the standard error of the mean (SEM).